Northern Trust Corp Roivant Sciences Ltd. Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 3,301,299 shares of ROIV stock, worth $38.1 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,301,299
Previous 3,448,082
4.26%
Holding current value
$38.1 Million
Previous $40.8 Million
18.34%
% of portfolio
0.01%
Previous 0.01%
Shares
14 transactions
Others Institutions Holding ROIV
# of Institutions
332Shares Held
496MCall Options Held
3.67MPut Options Held
754K-
Qvt Financial LP New York, NY65.8MShares$759 Million69.8% of portfolio
-
Sb Investment Advisers (Uk) LTD London, X061.9MShares$714 Million5.69% of portfolio
-
Viking Global Investors LP46MShares$531 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA40.8MShares$470 Million0.01% of portfolio
-
Morgan Stanley New York, NY35.9MShares$415 Million0.03% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.13B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...